This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Zacks News
January 2017 ETF Asset Scorecard
by Sanghamitra Saha
Inside the ETFs that generated and redeemed substantial assets in January.
Quality and Healthcare: 2 ETFs to Watch on Outsized Volume
by Sweta Killa
QDF and FHLC saw massive volumes in yesterday trading session.
What Does Dow's 20,000 Mean for These ETFs?
by Sanghamitra Saha
Dow finally hit the 20,000 mark, benefiting these ETFs. Will the rally last long?
IBM Tops, Guides Higher: ETFs in Focus
by Sweta Killa
IBM topped our earnings and revenue estimates and guided higher for 2017.
What's in Store for S&P 500 ETFs in 2017?
by Sanghamitra Saha
After the remarkable Trump rally in the end of 2016, will S&P 500 ETFs have more room to run in 2017?
2 Long/Short ETFs if You Fear Market Correction
by Sanghamitra Saha
With Trump's entry into the White House approaching, the market is becoming anxious. The anticipation punished stocks lately and benefited these long/short ETFs.
Should You Avoid IBM ETFs Ahead of Q4 Earnings?
by Sweta Killa
Our proven model shows that IBM might not surprise this quarter after beating our earnings estimates for eight consecutive quarters.
ETFs in Focus on Robust Q4 UnitedHealth Earnings
by Sweta Killa
Many investors may want to buy ETFs having the largest allocation to the giant health insurer.
January Chills Warm Gold ETFs: How Long Will the Shine Last?
by Sanghamitra Saha
Gold ETFs lately got back their glitter. How long will the rally continue?
Time to Prepare for 'Trump Slump' with These ETFs?
by Sanghamitra Saha
Lesser clarification on the fiscal boost in Trump's latest speech caught risk-on sentiments off-guard and may boost these high-quality and value ETFs ahead.